Department of Surgery Archive — Page 15 of 15
-
May 24, 2013
Preventable injuries filled Vanderbilt University Hospital last Memorial Day; Doctors urge safety on upcoming holiday
-
December 20, 2012
Cancer markers from archived tissue
Archived tissue samples are yielding new disease biomarkers. -
January 26, 2012
Investigators seek clues to resistance to melanoma drug
Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug. -
March 18, 2011
Protein combos keep cells straight
Researchers define the protein interactions that establish our organs' lining. -
April 18, 2006
Nationwide Breast Cancer Prevention Trial Resuts
Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant -
April 17, 2006
Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant
Initial Results of the Study of Tamoxifen and Raloxifene or STAR, released today revealed the osteoporosis drug raloxifene has been proved to be as effective as tamoxifen in preventing invasive breast cancer.